Unconfigured Ad
Collapse
X
-
We are using 2x300 kits. There is no feedback from Illumina. As detailed in this thread, if you feel that you did not get enough data, you can open a ticket with tech support and they may provide a free kit (this may be dependent on having a current maintenance contract).
-
Is anyone currently using these v3 600 kits? Anymore feedback from Illumina?Originally posted by ksawatzki View PostThis is a huge problem for us. We lost many thousands of dollars trying to
"fix" this problem on the library prep end, and we had tens of thousands of dollars allotted to sequencing on a government contract. Now the contract is over and we weren't able to get the sequencing done in time because of Illumina. We found a facility that still had semi-working kits, but we need Illumina to either officially announce their kit problem so our contract admin has a paper trail or pay for all the parts and labor independently.
Does anyone have any idea on who I can contact at Illumina? Our local rep just brushes us off, but this is not something we're going to just allow.
Leave a comment:
-
Has anyone heard of any developments re this issue?Originally posted by james hadfield View PostAt Illumina's UK UGM the team discussed the low quality at the end of long-read MiSeq kits. They acknowleged there was an issue and that they were actively working on it. However they have no plans to issue a quality notification until they understand the root cause. This issue has been rumbling on for months, at least a handful of invited users had not even heard of the problem.
Users need to be aware that 600 cycle kits are most likely not to work for long amplicons as the ends of both reads will drop in quality - badly.
The sentiment at the meeting was that issuing a quality notification to make sure customers are aware of this risks damaging confidence in these kits. Whilst many users will be unaffected (small random fragment genomes) or anyone sequencing under 500bp, the kit is clearly not delivering as expected in many long-read situations. Shareholders and investment banks may react negatively to a PQN, but without it too many users are in the dark.
Speak to your FAS and Sales team.
Leave a comment:
-
Use asymetric run mode with 600 cycle kits.
Actually the one should count not the number of the raw PF reads, but the number of good quality reads left after all preprocessing steps.Originally posted by dfhdfh View PostAfter talking to Illumina, they said it might be the library but they cannot exclude a failure of the reagents, so they sent new reagents. I went down from 1000 K/mm² to 700 K/mm² and increased PhiX from 5 % to 12 % and am now running the same library again. This costed me 8 M reads PF (down from 25 M to 17 M). I hope that it'll still be enough for the analysis.
Sometimes the 25M PF with 0.1% passed all processing steps is way worse, than 8M PF with 15% of reads passing preprocessing.
Also it can be quite helpful to do asymmetric 600 cycle runs - add some (10-15% of cycles from R2 to R1): instead of R1:300,I:6,R2:300,
run it in the R1:330,I:6,R2:270 mode, since last 30 - 50 cycles of the R2 are just wasting reagents better spent on the R1 read.
Leave a comment:
-
CEO's and presidents name are both on the Illumina website- maybe you should start at the top! If you succeed in getting any satisfaction let us know.....
Leave a comment:
-
Dear Ksawatzki,Originally posted by ksawatzki View PostYeah, I'm hoping that they'll be willing to help us since our paper trail involves a very early recognition of the problem, which we immediately brought to their attention. Our runs have definitely been a worst-case-scenario for them - not just quality drop off after 100-200bp, but a total loss of quality within 50bp. The exact same library was run at a different facility with older versions and worked relatively well, with the more normal drop off after a >150bp, pointing to the kit as the culprit.
My main question is if anyone has a lead on a good person at Illumina to contact. I'm pretty fired up about this whole incident, I'm not even sure how ethical it is for them to just pretend there's not a problem with the public while privately telling us the kit's not working.
Many peoples are complaining V3 kit issue.
Many seq core facilities are refusing V3.
Read these articles from everywhere.
Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform.--> http://www.ncbi.nlm.nih.gov/pubmed/25586220
A novel conceptual approach to read-filtering in high-throughput amplicon sequencing studies --> http://nar.oxfordjournals.org/conten...v1113.abstract
Rapid advances in sequencing technology have changed the experimental landscape of microbial ecology. In the last 10 years, the field has moved from sequencing hundreds of 16S rRNA gene fragments per study using clone libraries to the sequencing of millions of fragments per study using next-generati …
Bridged amplification & clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)
Bridged amplification & clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)
Before 2015 ends, I'd like to tie up two loose threads. In doing so, I'll deviate slightly from my usual pattern and publish two posts in ...
https://www.researchgate.net/post/wh...wer_than_i5923
Leave a comment:
-
Yeah, I'm hoping that they'll be willing to help us since our paper trail involves a very early recognition of the problem, which we immediately brought to their attention. Our runs have definitely been a worst-case-scenario for them - not just quality drop off after 100-200bp, but a total loss of quality within 50bp. The exact same library was run at a different facility with older versions and worked relatively well, with the more normal drop off after a >150bp, pointing to the kit as the culprit.
My main question is if anyone has a lead on a good person at Illumina to contact. I'm pretty fired up about this whole incident, I'm not even sure how ethical it is for them to just pretend there's not a problem with the public while privately telling us the kit's not working.
Leave a comment:
-
Illumina have already stated they will not release a PQN for this issue, so don't expect that to change...
Leave a comment:
-
Originally posted by Moorepark View PostWe also need to put pressure on for public announcement because for those who have to use 600 cycle, an announcement would get funding agencies off their backs.
This is a huge problem for us. We lost many thousands of dollars trying to
"fix" this problem on the library prep end, and we had tens of thousands of dollars allotted to sequencing on a government contract. Now the contract is over and we weren't able to get the sequencing done in time because of Illumina. We found a facility that still had semi-working kits, but we need Illumina to either officially announce their kit problem so our contract admin has a paper trail or pay for all the parts and labor independently.
Does anyone have any idea on who I can contact at Illumina? Our local rep just brushes us off, but this is not something we're going to just allow.
Leave a comment:
-
-
hi,we follow the Illumina 16S metagenomic method-so fragment is about 430bp,we thought it would be too short for overlap with 2 x 250bp but actually we're getting good joining efficiencies. It's not ideal, but more trustworthy than the garbage 600 cycle. We run less samples (usually 50 instead of 100) to compensate for lower output and we've included amplicons from previous runs to make sure clustering as before etc....We have one client though with longer amplicon (>500bp) and we can't help at all....it's embarrassing trying to explain when Illumina won't make an announcement. Hope that helps!
Leave a comment:
-
Hi Moorepark, it's good to hear that the 16S runs perform better with the V2 500 kit. Tech support has offered us to replace V3 600 kits with the V2 500 and also provide us with more Indexing kits. What fragment length do you run on the 500 kit? Would it be possible to get information regarding which protocol you're using? We are working on an EU financed project with deliverables by the end of the year, so we're pretty desperate...Last edited by toneta2013; 11-13-2015, 08:38 AM.
Leave a comment:
-
Hi all, have not read all the messages but get the overall stress! We have had problems with 600 cycle since approx Jan.We run primarily 16S libraries,quality on 600 used to be ok (in spec anyway, and we had such high read no.s we could afford to filter out some poor quality).Around Jan, started dropping, subtle change at first, but by May 2015 Read 4 (=read 2 we have dual indicing) was down to ~50% >Q30 and joining efficiencies were non-existant. Read 1 also poor. We have been engaging with Illumina on this since March and it is definitely a reagent issue, Illumina admitted as much to us and we've abandoned 600 cycle since then.We tried running low sample number, and included amplicons from good runs in the mix, but read numbers are so low data is unreliable and not consistent with previous good runs.Also tried increasing phi X etc but with increased phix and decreased sample, read numbers were too low so abandoned 600 cycle pretty much. we're running 500 cycle V2 since then. Apparently those kits also effected but not as badly, most have been fine for us. We ran one library on out of date kit and got average Q30 at 82%, same library two days later on new kit- quality at 69%- so there is an effect, but we still got enough data.most 500 cycle higher than that anyway. My big thing I want to say is I was just at a Users meeting in the UK. We asked why Illumina had not yet made a public announcement on this and were told "There will be no public announcement until we have 100% identified the problem and removed it". I.e. they're still making money selling the kits and it's cheaper to replace the ones from people who complain than withdraw everything. Problem for them is the issues are not even consistent, some people also seeing awful index reads but ok everything else, sometimes we get really high CD when we know we loaded similar amounts to previous....a lot of strange things going on...bottom line, you run a bad 600 cycle, go straight to them and say you want replacements, and switch to 500 if you can. A lot of people at meeting were not running 600 cycle routinely, so when they got a bad run, they blamed library and didn't pursue it, they were shocked to hear this is going on almost a year! We also need to put pressure on for public announcement because for those who have to use 600 cycle, an announcement would get funding agencies off their backs.
Leave a comment:
-
Here is the quality histogram for a recent 2x300bp 16s sequencing run. It's V3/V4 or V5/V6 or something like that.Originally posted by toneta2013 View PostCould you please provide a snapshot of a Fastqc-report from a successful run?
The quality is very low and causes a terrible merge rate despite the fact that they are fully overlapping. "linear" is what fastQC reports; "log" is the quality based on the actual expected error rates; and "measured" is based on mapping (we have the reference genomes for this metagenome).Attached Files
Leave a comment:
-
My idea is that the missing information about the quality problem it's a little bit naive for a big company like Illumina? I'm just saying this because its impossible to change something in a procedure, in this kind of companies, and say that they don't know about this.
In our experiments looks like that even in small amplicons (metagenomic protocol), users are complaining about the low quality at the ends.
Leave a comment:
Latest Articles
Collapse
-
by SEQadmin2
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...-
Channel: Articles
10-30-2026, 06:46 AM -
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, 10-28-2026, 09:57 AM
|
0 responses
41 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:57 AM
|
||
|
Started by SEQadmin2, 10-28-2026, 09:51 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
74 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
48 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Leave a comment: